Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression

1 Dec 2012

Abstract excerpt

BACKGROUND: Prostate cancer (PCa) is a leading cause of cancer death, and distinguishing aggressive from indolent tumors is a major challenge. Identification and characterization of genomic alterations associated with advanced disease can provide new markers of progression and better therapeutic approaches. METHODS: We performed fluorescence in situ hybridization to detect the copy number gain of chromosome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23401739
DOI: 10.1593/tlo.12286

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease ProgressionPMID 23401739Read ↗

Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer.Semantic proximity Read ↗

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterationsSemantic proximity Read ↗

Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerSemantic proximity Read ↗

High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancerSemantic proximity Read ↗

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancerSemantic proximity Read ↗

CRISPR screening reveals SYCP3 as a key driver of metastasis in prostate cancerSemantic proximity Read ↗

The PI3 kinase signaling pathway in prostate cancer.Semantic proximity Read ↗

Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expressionSemantic proximity Read ↗

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerSemantic proximity Read ↗

Statistical dissection of genetic pathways involved in prostate carcinogenesisSemantic proximity Read ↗

Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.Semantic proximity Read ↗

Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.